Navigation Links
Nepstar Chain Drugstore (NPD) Greenshoe Fully Exercised
Date:11/15/2007

SHENZHEN, China, Nov. 15 /Xinhua-PRNewswire-FirstCall/ -- China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or "the Company"), the largest retail drugstore chain in China based on the number of directly operated stores, announced today that the underwriters of the Company's initial public offering ("IPO") have exercised their greenshoe option in full to purchase 3,093,750 American Depositary Shares ("ADSs") from the Company at the IPO price of US$16.20 per ADS less the underwriting discount. The option was granted in connection with the Company's IPO, which was priced on November 8, 2007.

Including proceeds from the exercise of the greenshoe option, gross proceeds from the Company's IPO would increase to approximately US$384.2million.

Jiannong Qian, Nepstar's Chief Executive Officer, said: "We are delighted that investors have received our ADSs warmly. The funds raised from our IPO will enable us to further expand our store network and take other measures to reinforce our leading position in China's retail drugstore industry."

Goldman Sachs (Asia) L.L.C. was the sole global coordinator of the offering. Goldman Sachs (Asia) L.L.C. and Merrill Lynch, Pierce, Fenner & Smith Incorporated were the joint bookrunners. CLSA Limited was a co-manager of the offering.

Nepstar's registration statement relating to these securities has been declared effective by the United States Securities and Exchange Commission. This news release does not constitute an offer to sell or a solicitation of an offer to buy the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or q
'/>"/>

SOURCE China Nepstar Chain Drugstore Ltd.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. China Nepstar Chain Drugstore (NPD) Begins Trading on NYSE
2. With the Largest-Ever Buyout of a National Nursing Home Chain Pending ... New York Times Exposes Harm to Seniors After Private Equity Buyouts of Nursing Homes
3. NutritionPedia Adds Nutrition Facts for Over 6,000 Menu Items From 70 Leading Fast-Casual and Family Dining Restaurant Chains
4. IntegriChain Enlists Ed Casey and Associates to Drive Counterfeit and Diversion Monitoring Service
5. SEIU Launches Multi-State Grassroots Campaign Calling on the Carlyle Group to Put Care Above Profits in Buyout of Nations Largest Nursing Home Chain
6. Demonstration at Carlyle Group Offices Monday as Grassroots Caravan of Caregivers, Senior Advocates Arrives in D.C. to Speak Out for Improved Care, Staffing at Nations Largest Nursing Home Chain
7. DoD and VA to Reduce Healthcare Supply Chain Costs
8. Are Bargaining Groups Hired by Independent Drugstores Causing Payment Delays to Pharmacies?
9. PCMA Statement on the Independent Drugstore Lobby Agenda
10. drugstore.com and Revolution Health Group Announce Breakthrough Deal
11. drugstore.com, inc. to Announce Third Quarter 2007 Results During Conference Call on Monday, October 22, 2007 at 5:00 p.m. ET
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2008)...ence Call Scheduled Tuesday, August 5, 2008 at 11:...e-FirstCall/ -- Almost Family, Inc.,(Nasdaq: AFAM...sing,services, announced today that it will report..., 2008 on Tuesday, August 5, 2008, before the,mark... will begin at 11:00 a.m. ET on,August 5, 2008 and...
(Date:7/23/2008)...ON, N.J., July 23 /PRNewswire-USNewswire/ -- The N...lity and Patient Safety has,received a planning gr...dation (RWJF) to develop a proposal for improving ...nt will help determine over the next six months wh...ning Forces for Quality initiative,which is focus...
(Date:7/23/2008)..., China, July 23 /Xinhua-PRNewswire-FirstCall/ -- ...letin Board: GTEC) ("Genesis" or,the "Company"), a...public,of China, held a Board of Directors meeting...appointed to serve on the Board of Directors of th...on Committee were formed., Mr. Michael Marks was ...
(Date:7/23/2008)...ERSBURG, Fla., July 23 /PRNewswire/ -- Laura Kolkm...gnized health information exchange,consulting firm...hcare,Information and Management Systems Society (...ing Committee., The HIE Steering Committee, which...ng providers, payers, vendors, consultants and lif...
Breaking Medicine News(10 mins):Health News:Almost Family, Inc. to Report Second Quarter 2008 Financial Results 2Health News:Genesis Pharmaceuticals Announces New Board Member and Forms Committees 2Health News:Genesis Pharmaceuticals Announces New Board Member and Forms Committees 3Health News:Genesis Pharmaceuticals Announces New Board Member and Forms Committees 4Health News:Mosaica Partners' Kolkman to Chair HIMSS Healthcare Information Exchange Steering Committee 2
...ntion Research Center will bring tailored programs...e abuse . The outcome is based on decades of resea...ther high-risk behaviors of teenagers and adults. ...ion, 5-year grant from the National Institute of D...
...y soon impact the quality of patient care for asth...port. Without intervention, the number of allergy... 7 percent while demand will increase by 35 percen...ears, said ACAAI President Daniel Ein, M.D. The d...
...y warned consumers could be seriously misled by pr...mission to Food Standards Australia and New Zealan... manufacturers are likely to confuse consumers and... unhealthy diets. The food industry wants to put...
...ensitive caption for the picture of an abandoned b... a pre-schooler was found left in a cardboard box... The drop-off was opened by the Catholic-run Jikei...oto to discourage abortions and the abandonment of...
Other Medicine News:Health News:New Substance Use Prevention Program Being Developed 2Health News:New Substance Use Prevention Program Being Developed 3Health News:New Substance Use Prevention Program Being Developed 4Health News:America on Brink of Allergy Crisis 2Health News:Three-year-old Abandoned in Box Meant for Unwanted Babies in Japan 2
(Date:7/22/2008)...is Technology in the European ...wswire-FirstCall/ -- Cynosure, Inc.,(Nasdaq: CYNO...d array of,light-based aesthetic treatment systems...MPX(TM), the company,s high-powered, dual-waveleng...n skin through collagen,remodeling. The CE Mark ce...
(Date:7/21/2008)... as consolidation therapy after remission inducti...r lymphoma, SEATTL...tics, Inc.,(CTI) (Nasdaq and MTA: CTIC) announced ...h the U.S. Food and Drug Administration (FDA) in S...pplemental Biologics License,Application (sBLA) fo...
(Date:7/21/2008)...008 conferences, GAITHERSBURG, Md., July 21 /PRNe...ompany developing gene therapies for HIV and genet...Phase I and Phase II,clinical trials for the media...an investigational gene therapy for the treatment ...day, July 24, 2008 at 11 a.m. EDT. The,presentatio...
(Date:7/21/2008)...h in Italy continue, FRANKLIN, Mass., July 21 /PR...C ) announced today that it will defer the commenc...TM) System in the prevention of,Contrast-Induced N... the,investigator-sponsored clinical trial now ong... launch of RenalGuard in Europe, which began in th...
Breaking Medicine Technology:Cynosure Receives CE Mark for Smartlipo MPX(TM) Workstation 2Cynosure Receives CE Mark for Smartlipo MPX(TM) Workstation 3CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R) 2CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R) 3CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R) 4VIRxSYS to Host a Web Conference to Announce Clinical Trial Update 2VIRxSYS to Host a Web Conference to Announce Clinical Trial Update 3VIRxSYS to Host a Web Conference to Announce Clinical Trial Update 4VIRxSYS to Host a Web Conference to Announce Clinical Trial Update 5PLC Systems Defers Pivotal Study of RenalGuard(TM) in the U.S. 2PLC Systems Defers Pivotal Study of RenalGuard(TM) in the U.S. 3PLC Systems Defers Pivotal Study of RenalGuard(TM) in the U.S. 4PLC Systems Defers Pivotal Study of RenalGuard(TM) in the U.S. 5Statehouse Atrium to be Site for Childrens Dental Access Event Ohio Legislators to Mingle With Children and Dentists for This Free Care Event 21 9781 1Statehouse Atrium to be Site for Childrens Dental Access Event Ohio Legislators to Mingle With Children and Dentists for This Free Care Event 21 9781 2Barr Will Host Calendar 2007 and Fourth Quarter Earnings Conference Call on February 28 2008 2664 1Barr Will Host Calendar 2007 and Fourth Quarter Earnings Conference Call on February 28 2008 2664 2Barr Will Host Calendar 2007 and Fourth Quarter Earnings Conference Call on February 28 2008 2664 3Abbott Announces Approval of First Fully Automated Blood Screening Test for HTLV I HTLV II 2662 1Abbott Announces Approval of First Fully Automated Blood Screening Test for HTLV I HTLV II 2662 2Abbott Announces Approval of First Fully Automated Blood Screening Test for HTLV I HTLV II 2662 3Advanced Life Sciences to Host Conference Call to Discuss Announcement Made Yesterday by FDA to Conduct Advisory Panel on CAP Drug Development 2660 1Advanced Life Sciences to Host Conference Call to Discuss Announcement Made Yesterday by FDA to Conduct Advisory Panel on CAP Drug Development 2660 2Advanced Life Sciences to Host Conference Call to Discuss Announcement Made Yesterday by FDA to Conduct Advisory Panel on CAP Drug Development 2660 3
... Rexahn,Pharmaceuticals, Inc. (OTC BB:RXHN), a bio... development, and commercialization of,innovative ...rders,sexual dysfunction and other unmet medical ...ncipal Investigator of Phase I clinical,trial of t...n),will present results of the clinical study at ...
...n Transplantation, HORSHOLM, Denmark, May 31, 2007...ces positive Phase I clinical results for,its tran...nto US,Phase II clinical trials for organ transpla...nounces positive results,from its Phase I clinical...aily tacrolimus tablet. , A series of Phase I tria...
Other Medicine Technology:LifeCycle Pharma Announces Positive Phase I Clinical Results for,its Transplantation Product Candidate, LCP-Tacro 2LifeCycle Pharma Announces Positive Phase I Clinical Results for,its Transplantation Product Candidate, LCP-Tacro 3
GENTAMICIN SULFATE, 1000X
Gentamicin is a selection antibiotic used for selection of a Bac-to-Bac recombinant expression bacmid following transposition. Gentamicin is provided as a solution at a concentration of 50 mg/ml.
1.0% Tryptone, 0.5% yeast extract, 0.5% Sodium Chloride, 1.5% agarose.
1% tryptone, 0.5% yeast extract, 1.0% Sodium Chloride, 1.5% agar.
Medicine Products: